Skip to main content
. 2021 Oct 18;41(12):2826–2833. doi: 10.1038/s41372-021-01220-5

Fig. 1. Radar plot of stakeholder perspectives about preclinical research.

Fig. 1

The proportion of respondents from each stakeholder group is shown for the prompt that “preclinical research provides an assessment of safety that is adequate to proceed to conducting a drug study in neonates”. The responses by Neonatologists (n = 37) are shown in a blue line. The responses by Nurses (n = 130) are shown in an orange line. The responses by parents (n = 49) are shown in a grey line.